samedan logo
 
 
 
spacer
home > pmps > summer 2020 > synergistic relations
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Synergistic Relations

In this fast-paced and complex technical and regulatory environment, pharmaceutical and biotechnology companies are looking for new ways to become more efficient while building processes that deliver new drugs to market in a timely, cost-effective manner.

Partnerships or collaborations can enable an assortment of value- added benefits that can also lead to competitive advantage in the market. The concept of collaboration is about changing the functional business model from one that is vertical in nature to one that is a broader, network concept.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Fran DeGrazio has over 35 years’ experience in the pharma packaging and delivery industry, with extensive expertise in injectable drug products, including vial container closure systems, and pre-fillable systems for combination products. Fran has held numerous technical roles at West Pharmaceutical Services, Inc, including R&D, Quality & Regulatory, Technical Customer Support, Analytical Laboratories, and Scientific Affairs. In her current role as Chief Scientific Officer, she is responsible to leverage scientific and regulatory understanding across the enterprise. Fran received the Philadelphia Business Journal 2018 Healthcare Innovators of the Greater Philadelphia Region Award and the Healthcare Business Woman’s Association Luminary Award for West in 2017.
spacer
Fran DeGrazio at West Pharmaceutical Services, Inc
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma and Memo Therapeutics AG collaborate on the fast-track manufacturing of a SARS-CoV-2- neutralizing antibody for the therapy of COVID-19

Vilnius, Lithuania, and Schlieren, Switzerland – August 11, 2020 – Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Swiss biotech company Memo Therapeutics AG (MTx), announce a new partnership to manufacture MTx’s therapeutic COVID-19 antibody candidate in a 4-month fast-track process approved by regulatory authorities.
More info >>

White Papers

BioT ULT Transporter

BioCision

The growth of biobanking, cell therapy, and complex biopharmaceutical therapies like cancer vaccines has created a strong need for products and processes to ensure the stability of temperature­-sensitive biospecimens. Proper collection, handling, characterization, packaging and shipping of these materials is critical, as poor sample handling impacts researchers working on discovery with patient samples, as well as clinicians treating patients with cutting edge therapies. This white paper describes in detail the BioCision BioT™ ULT Transporter, the first-of-its-kind dry ice-based portable cooling system that maintains a stable -75° to -50°C environment for over 24 hours on one charge of dry ice, enabling reliable handling and transfer of valuable temperature-sensitive biospecimens as part of a larger cold chain standardization process.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement